Trisalus Life Sciences Inc (TLSI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Operating Expenses | 670 | 1,142 | 807 | 784 | 308 |
| Operating Income | -670 | -1,142 | -807 | -784 | -308 |
| Other Income | 3,507 | 4,037 | 2,672 | 1,163 | -64 |
| Pre-tax Income | 2,837 | 2,896 | 1,865 | 379 | -372 |
| Net Income Continuous | 2,837 | 2,896 | 1,865 | 379 | -372 |
| Net Income | $2,837 | $2,896 | $1,865 | $379 | $-372 |
| EPS Basic Total Ops | 0.09 | 0.09 | 0.06 | 0.01 | -0.01 |
| EPS Basic Continuous Ops | 0.45 | 0.46 | 0.30 | 0.06 | -0.06 |
| EPS Diluted Total Ops | 0.09 | 0.09 | 0.06 | 0.01 | -0.01 |
| EPS Diluted Continuous Ops | 0.45 | 0.46 | 0.30 | 0.06 | -0.06 |
| EBITDA(a) | $-670 | $-1,142 | $-807 | $-784 | $-308 |